Skip to main content
Skip to main content
UFPT logo

UFP Technologies, Inc. (UFPT) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$277.40 -$1.19 (-0.43%) |Exceptional · 88
UFP Technologies, Inc. (UFPT) bottom line: Bullish Lean — our Council read (73/100) and AI Score (88/100) broadly agree. Strongest signal: Growth Durability · Biggest watch-out: Valuation.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $2.15B| P/E Ratio: 29.64| Vol: 91.8K| 52-wk range: $173.86 – $338.71

P/E 29.64 means the share price is 29.64 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $2.15B is the value of all shares combined. Beta 1.17: the stock has moved about 17% more than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

UFP Technologies, Inc. (UFPT) trades at $277.40 with MoonshotScore 88/100 (Grade A+). UFP Technologies, Inc. specializes in designing and manufacturing custom components and packaging solutions, primarily for the medical market. Market cap: $2.15B, Sector: Healthcare.

Price as of Sep 11, 2026 · Last analyzed: May 10, 2026
UFP Technologies, Inc. specializes in designing and manufacturing custom components and packaging solutions, primarily for the medical market. The company leverages specialized foams, films, and plastics to serve diverse sectors, including automotive, aerospace, defense, consumer, electronics, and industrial.

Analyst Coverage for UFPT: UFPT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates UFPT against Healthcare peers across nine fundamental dimensions and assigns a relatively strong fundamental profile based on the underlying data.

Watch the UFPT film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

Council Score · Weighted Average of 3 Disciplines
Bullish Lean 73/100 · A

UFPT: 3/3 scored disciplines lean bullish. Dominant signal: Growth Durability strong.

How is this calculated? →
MoonshotScore · Five-pillar engine · 88/100
Business Quality
Strong Is this a genuinely good business?
Financial Safety
Moderate Could this blow up on me?
Valuation
Neutral Am I paying a fair price?
Growth Durability
Strong Is the growth real and likely to last?
Momentum
Moderate Is the market already moving on this?

Strongest side: Growth Durability (9/10, Strong). Weakest side: Valuation (5/10, Neutral).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Neutral read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Favorable read
Klarman-style lens (simulated)Seth Klarman
Favorable read
Moon AI lens (model)
Favorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Moderate
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

UFP Technologies, Inc. (UFPT) Healthcare & Pipeline Overview

CEOR. Jeffrey Bailly
Employees4,846
HeadquartersNewburyport, MA, US
IPO Year1993

UFP Technologies, Inc. (UFPT) is a custom manufacturer specializing in single-use medical devices and components, leveraging specialized foams, films, and plastics. With a strong foothold in the healthcare sector, the company also serves automotive, aerospace, and defense industries, distinguishing itself through custom solutions and a direct sales approach.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for UFPT?

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

With a market capitalization of $2.15B and a P/E ratio of 29.64, the company demonstrates solid financial health. A key value driver is its focus on single-use medical devices, aligning with increasing healthcare demands for infection control and patient safety. Growth catalysts include expanding its product offerings in high-growth areas such as minimally invasive surgery and wearable medical devices. However, investors may want to evaluate potential risks, including competition from other materials manufacturers and dependence on key customer relationships. The company's ability to maintain its 11.3% profit margin and 28.4% gross margin will be crucial for sustained profitability.

Based on FMP financials and quantitative analysis

UFPT Key Highlights

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $2.15B reflects investor confidence in UFPT's market position and growth potential.

  • P/E ratio of 29.64 indicates a premium valuation, suggesting expectations of future earnings growth.
  • Profit margin of 11.3% demonstrates efficient operations and pricing strategies.
  • Gross margin of 28.4% highlights the value-added nature of UFPT's custom manufacturing capabilities.
  • Beta of 1.17 suggests UFPT's stock price is slightly more volatile than the overall market.

Who Are UFPT's Competitors?

UFPT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
INSP Inspire Medical Systems, Inc. $73.00 +7.16% $2.11B 975-pillar
ESTA Establishment Labs Holdings Inc. $70.39 -1.40% $2.07B 345-pillar
AXGN AxoGen, Inc. $41.85 -11.47% $2.25B 365-pillar
TMDX TransMedics Group, Inc. $82.18 -3.36% $2.84B 765-pillar
NHNKY Nihon Kohden Corporation $10.01 +4.71% $3.20B 489-signal
MDRSF Medartis Holding AG $115.00 0.00% $1.43B 529-signal
ELEAF EL.En. S.p.A. $17.50 0.00% $1.40B 469-signal
CNMD CONMED Corporation $46.22 -1.51% $1.38B 765-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are UFPT's Key Strengths?

Strong position in the medical device component market.

  • Expertise in custom manufacturing and specialized materials.
  • Diversified customer base across multiple industries.
  • Established long-term customer relationships.

What Are UFPT's Weaknesses?

Dependence on direct sales force in the United States.

  • Potential for fluctuations in raw material costs.
  • Limited brand recognition compared to larger competitors.
  • Exposure to regulatory changes in the medical device industry.

What Could Drive UFPT Stock Higher?

UFPT catalyst: Expansion of product offerings in high-growth areas such as minimally invasive surgery and wearable medical devices.

  • Strategic partnerships with leading medical device manufacturers to secure long-term contracts.
  • Potential acquisitions of smaller companies with complementary technologies or product lines.
  • Continued investment in research and development to create innovative materials and solutions.

What Are the Key Risks for UFPT?

Rich valuation — a P/E of 29.64 runs well above the Healthcare sector’s ~21.50x, leaving little room for a miss.

  • Insider selling — insiders were net sellers of roughly $13.1M recently.
  • Intense competition from other materials manufacturers.
  • Fluctuations in raw material costs impacting profitability.
  • Product liability claims related to medical device components.
  • Economic downturns impacting demand in various industries.
  • Regulatory changes in the medical device industry.

What Are the Growth Opportunities for UFPT?

  • Expansion in Minimally Invasive Surgery Components: The market for minimally invasive surgery (MIS) is experiencing rapid growth due to reduced patient recovery times and lower healthcare costs. UFP Technologies can capitalize on this trend by developing and manufacturing specialized foam and plastic components for MIS devices. This market segment is projected to reach $36 billion by 2028, offering a substantial growth opportunity for UFPT. By leveraging its expertise in custom materials and design, UFPT can secure contracts with leading MIS device manufacturers.
  • Penetration of the Wearable Medical Device Market: The wearable medical device market is expanding rapidly, driven by increasing consumer interest in remote patient monitoring and personalized healthcare. UFP Technologies can leverage its materials expertise to develop comfortable, biocompatible components for wearable sensors, drug delivery systems, and monitoring devices. The global wearable medical device market is expected to reach $29.6 billion by 2029, presenting a significant growth avenue for UFPT. Strategic partnerships with wearable device companies will be crucial for market penetration.
  • Geographic Expansion into Emerging Markets: Expanding its sales and manufacturing presence in emerging markets, particularly in Asia-Pacific, represents a significant growth opportunity for UFP Technologies. The increasing healthcare spending and growing demand for advanced medical devices in these regions create a favorable environment for UFPT's products. Establishing strategic partnerships with local distributors and manufacturers will be essential for navigating regulatory hurdles and gaining market access. This expansion could increase revenue by 15% over the next five years.
  • Development of Advanced Materials for Orthopedic Implants: The orthopedic implant market is continuously evolving, with a growing demand for advanced materials that enhance biocompatibility, durability, and patient comfort. UFP Technologies can invest in research and development to create innovative foam and plastic materials for orthopedic implants and soft goods. This includes exploring materials with improved antimicrobial properties and enhanced structural integrity. Successful development and commercialization of these materials could significantly boost UFPT's revenue and market share in the orthopedic sector.
  • Strategic Acquisitions to Expand Product Portfolio: UFP Technologies can pursue strategic acquisitions of smaller companies with complementary technologies or product lines to expand its portfolio and market reach. This includes targeting companies specializing in advanced materials, medical device components, or packaging solutions. Acquisitions can provide UFPT with access to new technologies, customer relationships, and geographic markets, accelerating its growth trajectory. Careful due diligence and integration planning will be crucial for maximizing the value of these acquisitions.

What Are UFPT's Competitive Advantages?

  • Customization Capabilities: UFP Technologies' ability to design and manufacture custom components tailored to specific customer needs provides a competitive advantage.
  • Material Expertise: The company's expertise in specialized foams, films, and plastics allows it to create unique and high-performance solutions.
  • Long-Standing Customer Relationships: UFP Technologies has established long-term relationships with key customers across various industries, creating switching costs and repeat business.
  • Diversified End Markets: Serving a diverse range of industries reduces the company's dependence on any single market, mitigating risk and providing stability.

What Does UFPT Do?

Founded in 1963 and headquartered in Newburyport, Massachusetts, UFP Technologies, Inc. has evolved into a leading designer and manufacturer of custom-engineered solutions utilizing specialized foams, films, and plastics. Initially serving various industrial sectors, the company strategically shifted its focus towards the medical market, now its primary revenue driver. UFP Technologies provides single-use and single-patient devices and components integral to medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. Beyond healthcare, UFP Technologies continues to serve the automotive, aerospace and defense, consumer, electronics, and industrial markets. These solutions range from military uniform and gear components and automotive interior trim to athletic padding, environmentally protective packaging, air filtration, abrasive nail files, and protective cases and inserts. The company markets and sells its products primarily through a direct sales force within the United States, supplemented by independent manufacturer representatives, ensuring close customer relationships and tailored solutions.

What Products and Services Does UFPT Offer?

  • Designs and manufactures custom components for medical devices.
  • Produces single-use and single-patient devices for the healthcare industry.
  • Creates specialized packaging solutions for medical implants and instruments.
  • Supplies engineered products for the automotive industry, including interior trim components.
  • Provides protective components for military uniforms and gear.
  • Offers custom solutions for the aerospace and defense sectors.
  • Manufactures components for consumer products, such as athletic padding and protective cases.
  • Develops specialized components for the electronics and industrial markets.

How Does UFPT Make Money?

  • Custom Manufacturing: UFP Technologies generates revenue by designing and manufacturing custom components and products based on specific customer requirements.
  • Direct Sales: The company primarily utilizes a direct sales force to market and sell its products within the United States, fostering close customer relationships.
  • Diversified Markets: UFP Technologies serves a diverse range of industries, including medical, automotive, aerospace, defense, consumer, electronics, and industrial, mitigating risk through market diversification.
  • Value-Added Solutions: The company focuses on providing value-added solutions through its expertise in specialized foams, films, and plastics, differentiating itself from competitors.

What Industry Does UFPT Operate In?

UFP Technologies operates within the medical device industry, a sector characterized by continuous innovation and stringent regulatory requirements. The market for medical device components is projected to grow, driven by an aging population, increasing prevalence of chronic diseases, and technological advancements in medical treatments. Competition is intense, with companies vying for market share through product differentiation and strategic partnerships. UFP Technologies distinguishes itself through its focus on custom manufacturing and its ability to provide specialized solutions for diverse medical applications. The company's expansion into high-growth areas such as minimally invasive surgery and wearable medical devices positions it favorably within the evolving healthcare landscape.

Who Are UFPT's Key Customers?

  • Medical Device Manufacturers: Companies that produce medical devices and require custom components for their products.
  • Automotive Companies: Manufacturers of automobiles that utilize UFP Technologies' products for interior trim and other applications.
  • Aerospace and Defense Contractors: Companies that provide products and services to the aerospace and defense industries and require specialized components.
  • Consumer Product Companies: Businesses that manufacture consumer products and require custom components for their goods.
Model self-rating on this text: 73% (not a measure of the evidence) Updated: May 10, 2026

Research confidence

Medium 60/100

Enough evidence to be useful, with gaps worth knowing about.

  • Scored on 100% of our measures
  • Price is current
  • No filing on record
  • No analyst coverage

Why 88?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.54 Financial-health checklist (Financial Strength)
  • +0.44 Return on equity (Business Quality)
  • +0.33 Gross profit per dollar of assets (Business Quality)

What is holding it back

  • -0.21 Debt to equity (Financial Strength)
  • -0.10 Enterprise value vs free cash flow (Valuation)
  • -0.08 Price to book (Valuation)

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 88
2026-08-26 89
2026-08-29 90
2026-09-01 88
2026-09-04 87
2026-09-07 81
2026-09-10 88

What changed?

The score has stayed at 88.

What moved it up or down:

  • -18 Valuation
  • +6 Financial Safety
  • +1 Business Quality

Over the same 18 days the stock moved -9.9%.

UFP Technologies, Inc. (UFPT) Valuation Context

Valued at $2.15B, UFPT is classified as a mid-cap stock. Relative to its peer group, UFPT's quantitative score of 88/100 is above the peer average of 58/100.

UFPT Revenue & Earnings Trend

In Jun 2026, UFPT generated $174.0M in top-line revenue, marking a sequential increase of 12.8%. The company recorded net income of $20.9M, with diluted EPS of $2.67. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this mid-cap Healthcare company. Across the four most recent quarters, UFPT averaged $2.32 in diluted EPS.

Company Profile

UFP Technologies, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Newburyport, US. The company is led by CEO Mitchell C. Rock. UFPT has traded publicly since 1993.

ROE 17%

Key Financial Metrics

Return on equity for UFP Technologies, Inc. stands at 16.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 10.6%, showing how much profit it generates from its asset base. UFPT trades at a trailing price-to-earnings ratio of 29.64, above the Healthcare sector average of ~21.50x. Its free cash flow yield is 2.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.00 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.4%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 7/9

Financial Health

UFP Technologies, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 8.36 places it in the safe zone, indicating low near-term bankruptcy risk.

8/8 beats

Earnings Track Record

UFP Technologies, Inc. has beaten Wall Street's EPS estimate in 8 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 13.3% above estimates on average.

FY2026 est

Forward Outlook

Wall Street analysts project UFP Technologies, Inc. revenue of about $657.8M for fiscal 2026, with EPS near $9.74. The estimate reflects 3 contributing analysts.

Net selling

Insider Activity

Over the past six months, UFP Technologies, Inc. insiders filed 28 SEC Form 4 transactions — 19 sales and 9 purchases. On net that is roughly 30K shares disposed (about $13.1M), a signal worth weighing alongside the fundamentals.

UFPT Financials

Fundamental Snapshot

Revenue Growth (FY)
+19.5%
Net Income Growth (FY)
+15.8%
EPS Growth (FY)
+15.3%
Free Cash Flow Growth (FY)
+38.7%
P/E (TTM)
29.64
Return on Equity (TTM)
+16.7%
Current Ratio
3.0
EV/EBITDA (TTM)
19.6

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Strong position in the medical device component market.
  • Expertise in custom manufacturing and specialized materials.
  • Diversified customer base across multiple industries.
  • Established long-term customer relationships.

Bear Case

  • Dependence on direct sales force in the United States.
  • Potential for fluctuations in raw material costs.
  • Limited brand recognition compared to larger competitors.
  • Exposure to regulatory changes in the medical device industry.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Jun 2026 $174M $21M $2.67
Mar 2026 $154M $17M $2.24
Dec 2025 $149M $18M $2.25
Sep 2025 $155M $16M $2.11

Based on FMP financials and quantitative analysis

UFPT Latest News

UFPT Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for UFPT.

Price Targets

Wall Street price target analysis for UFPT.

UFPT MoonshotScore

88/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. UFPT scores 88/100 (Grade A+): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Leadership: R. Jeffrey Bailly

CEO

R. Jeffrey Bailly serves as the Chief Executive Officer of UFP Technologies, Inc. His career spans several decades in the manufacturing and engineering sectors. He has a proven track record in strategic leadership, operational excellence, and driving profitable growth. Bailly's expertise lies in developing and implementing innovative solutions to meet customer needs and navigating complex market dynamics. His experience includes roles in various leadership positions, providing him with a comprehensive understanding of the industry landscape.

Track Record: Under R. Jeffrey Bailly's leadership, UFP Technologies has strengthened its position in the medical device component market and expanded its presence in other key industries. He has overseen strategic investments in research and development, resulting in the development of innovative materials and solutions. Bailly has also focused on enhancing operational efficiency and fostering a culture of continuous improvement. His leadership has contributed to the company's sustained profitability and growth.

What Investors Ask About UFP Technologies, Inc. (UFPT) — Healthcare

What does the AI Score mean for UFPT?

UFPT holds an AI Score of 88/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. UFP Technologies, Inc. specializes in designing and manufacturing custom components and packaging solutions, primarily for the medical market.

Is UFPT a good stock?

Stock Expert AI does not rate UFPT buy, sell or hold. UFP Technologies, Inc. carries a MoonshotScore of 88/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What are the main risks for UFPT?

UFP Technologies, Inc. faces several risks inherent to its industry and business model. Intense competition from other materials manufacturers could put pressure on pricing and margins.

What are the key factors to evaluate for UFPT?

UFP Technologies, Inc. (UFPT) holds a MoonshotScore of 88/100 (high). P/E: 29.64x vs the S&P 500's ~20-25x. Not financial advice.

How frequently does UFPT data refresh on this page?

UFPT's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven UFPT's recent stock price performance?

UFP Technologies, Inc. (UFPT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong position in the medical device component market. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider UFPT overvalued or undervalued right now?

UFP Technologies, Inc. (UFPT) trades at 29.64x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of UFPT?

Yes, most major brokerages offer fractional shares of UFP Technologies, Inc. (UFPT) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track UFPT's earnings and financial reports?

UFP Technologies, Inc. (UFPT) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for UFPT earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • Financial data is as of 2026-05-10.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover